{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:42:28Z","timestamp":1790944948572,"version":"4.1.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/mol.0b013e32813aeabf","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T04:04:14Z","timestamp":1178769854000},"page":"325-332","source":"Crossref","is-referenced-by-count":52,"title":["Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease"],"prefix":"10.1097","volume":"18","author":[{"given":"Veronica","family":"Hirsch-Reinshagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210205","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.genet.32.1.461","article-title":"Alzheimer's disease: genetic studies and transgenic models","volume":"32","author":"Price","year":"1998","journal-title":"Annu Rev Genet"},{"key":"R2-16-20210205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS\u2013ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"Suppl 3","key":"R3-16-20210205","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1212\/WNL.49.3_Suppl_3.S7","article-title":"Clinical assessment of Alzheimer's disease","volume":"49","author":"Morris","year":"1997","journal-title":"Neurology"},{"key":"R4-16-20210205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"R5-16-20210205","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in the human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bj\u00f6rkhem","year":"1998","journal-title":"J Lipid Res"},{"key":"R6-16-20210205","doi-asserted-by":"crossref","first-page":"30178","DOI":"10.1074\/jbc.272.48.30178","article-title":"Importance of a novel oxidative mechanism for elimination of brain cholesterol","volume":"272","author":"Bjorkhem","year":"1997","journal-title":"J Biol Chem"},{"key":"R7-16-20210205","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system","volume":"262","author":"Pitas","year":"1987","journal-title":"J Biol Chem"},{"key":"R8-16-20210205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1749-6632.2000.tb06365.x","article-title":"Lipoproteins in the central nervous system","volume":"903","author":"Ladu","year":"2000","journal-title":"Ann New York Acad Sci"},{"key":"R9-16-20210205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/bi00507a059","article-title":"Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification","volume":"20","author":"Zannis","year":"1981","journal-title":"Biochemistry"},{"key":"R10-16-20210205","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J Biol Chem"},{"key":"R11-16-20210205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"R12-16-20210205","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"R13-16-20210205","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-16-20210205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"key":"R15-16-20210205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid \u03b2 peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem J"},{"key":"R16-16-20210205","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid","volume":"270","author":"Ladu","year":"1995","journal-title":"J Biol Chem"},{"key":"R17-16-20210205","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to beta-amyloid","volume":"269","author":"Ladu","year":"1994","journal-title":"J Biol Chem"},{"key":"R18-16-20210205","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1021\/bi9626362","article-title":"Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide \u03b2 (1\u201340). Relevance to Alzheimer's disease","volume":"36","author":"Aleshkov","year":"1997","journal-title":"Biochemistry"},{"key":"R19-16-20210205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF03401614","article-title":"Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E","volume":"2","author":"Zhou","year":"1996","journal-title":"Mol Med"},{"key":"R20-16-20210205","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat Med"},{"key":"R21-16-20210205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/1097-0029(20000815)50:4<316::AID-JEMT11>3.0.CO;2-E","article-title":"Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein","volume":"50","author":"Cole","year":"2000","journal-title":"Microsc Res Tech"},{"key":"R22-16-20210205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Ann Neurol"},{"key":"R23-16-20210205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","article-title":"Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition","volume":"17","author":"Bales","year":"1997","journal-title":"Nat Genet"},{"key":"R24-16-20210205","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer's disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-16-20210205","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1172\/JCI6179","article-title":"Expression of human apolipoprotein E reduces amyloid-\u03b2 deposition in a mouse model of Alzheimer's disease","volume":"103","author":"Holtzman","year":"1999","journal-title":"J Clin Invest"},{"key":"R26-16-20210205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2004-6508","article-title":"Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Abeta deposition, in an AbetaPP\/PS double transgenic mouse model of Alzheimer's disease","volume":"6","author":"Costa","year":"2004","journal-title":"J Alzheimer's Dis"},{"key":"R27-16-20210205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2000.tb06919.x","article-title":"Modulation of A\u03b2 deposition in APP transgenic mice by an apolipoprotein E null background","volume":"920","author":"Irizarry","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"R28-16-20210205","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-16-20210205","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.1134","article-title":"Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain","volume":"50","author":"Carter","year":"2001","journal-title":"Ann Neurol"},{"key":"R30-16-20210205","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1523\/JNEUROSCI.22-24-10539.2002","article-title":"Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation","volume":"22","author":"Buttini","year":"2002","journal-title":"J Neurosci"},{"key":"R31-16-20210205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0409072102","article-title":"Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease","volume":"102","author":"Dodart","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R32-16-20210205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","article-title":"Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions","volume":"11","author":"Rebeck","year":"1993","journal-title":"Neuron"},{"key":"R33-16-20210205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","article-title":"Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease","volume":"69","author":"Nagy","year":"1995","journal-title":"Neuroscience"},{"key":"R34-16-20210205","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid \u03b2-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-16-20210205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","article-title":"Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype","volume":"55","author":"Berg","year":"1998","journal-title":"Arch Neurol"},{"key":"R36-16-20210205","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1212\/01.WNL.0000128091.92139.0F","article-title":"Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease","volume":"62","author":"Tiraboschi","year":"2004","journal-title":"Neurology"},{"key":"R37-16-20210205","doi-asserted-by":"crossref","first-page":"18521","DOI":"10.1016\/S0021-9258(17)32340-2","article-title":"Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons","volume":"269","author":"Bu","year":"1994","journal-title":"J Biol Chem"},{"key":"R38-16-20210205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.410370212","article-title":"Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor\/low-density-lipoprotein receptor-related protein","volume":"37","author":"Rebeck","year":"1995","journal-title":"Ann Neurol"},{"key":"R39-16-20210205","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1074\/jbc.M502143200","article-title":"The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice","volume":"280","author":"Fryer","year":"2005","journal-title":"J Biol Chem"},{"key":"R40-16-20210205","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1073\/pnas.0305803101","article-title":"Increased soluble amyloid-\u03b2 peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein","volume":"101","author":"Zerbinatti","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R41-16-20210205","doi-asserted-by":"crossref","first-page":"36180","DOI":"10.1074\/jbc.M604436200","article-title":"Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal A\u03b242 accumulation in amyloid model mice","volume":"281","author":"Zerbinatti","year":"2006","journal-title":"J Biol Chem"},{"key":"R42-16-20210205","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-{beta}1-40 peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"R44-16-20210205","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid \u03b2 at the blood\u2013brain and blood\u2013cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R45-16-20210205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/nbdi.2001.0470","article-title":"Cholesterol-dependent \u03b3-secretase activity in buoyant cholesterol-rich membrane microdomains","volume":"9","author":"Wahrle","year":"2002","journal-title":"Neurobiol Dis"},{"key":"R46-16-20210205","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1523\/JNEUROSCI.23-13-05645.2003","article-title":"Presenilin redistribution associated with aberrant cholesterol transport enhances \u03b2-amyloid production in vivo","volume":"23","author":"Burns","year":"2003","journal-title":"J Neurosci"},{"key":"R47-16-20210205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00001756-200203250-00019","article-title":"Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice","volume":"213","author":"Shie","year":"2002","journal-title":"Neuroreport"},{"key":"R48-16-20210205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol Dis"},{"key":"R49-16-20210205","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer's disease \u03b2-amyloid peptides A\u03b242 and A\u03b240 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R50-16-20210205","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R51-16-20210205","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of \u03b2-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R52-16-20210205","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1074\/jbc.271.8.4436","article-title":"Cholesterol modulates \u03b1-secretase cleavage of amyloid precursor protein","volume":"271","author":"Bodovitz","year":"1996","journal-title":"J Biol Chem"},{"key":"R53-16-20210205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2001-3207","article-title":"Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Abeta peptide","volume":"3","author":"Buxbaum","year":"2001","journal-title":"J Alzheimer's Dis"},{"key":"R54-16-20210205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J Cell Biol"},{"key":"R55-16-20210205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer's disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat Neurosci"},{"key":"R56-16-20210205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00041433-200004000-00003","article-title":"Cholesterol efflux regulatory protein. Tangier disease and familial high-density lipoprotein deficiency","volume":"11","author":"Hayden","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"R57-16-20210205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"R58-16-20210205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier Disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat Genet"},{"key":"R59-16-20210205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat Genet"},{"key":"R60-16-20210205","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1152\/physrev.00005.2005","article-title":"ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease","volume":"85","author":"Oram","year":"2005","journal-title":"Physiol Rev"},{"key":"R61-16-20210205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/labinvest.3780421","article-title":"ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation","volume":"82","author":"Wellington","year":"2002","journal-title":"Lab Invest"},{"key":"R62-16-20210205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI118082","article-title":"Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease","volume":"96","author":"Francis","year":"1995","journal-title":"J Clin Invest"},{"key":"R63-16-20210205","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1006\/bbrc.2000.4219","article-title":"Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter","volume":"280","author":"Remaley","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R64-16-20210205","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J Biol Chem"},{"key":"R65-16-20210205","doi-asserted-by":"crossref","first-page":"40987","DOI":"10.1074\/jbc.M407963200","article-title":"ABCA1 is required for normal CNS apoE levels and for lipidation of astrocyte-secreted apoE","volume":"279","author":"Wahrle","year":"2004","journal-title":"J Biol Chem"},{"key":"R66-16-20210205","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.1074\/jbc.M300760200","article-title":"Expression of LXR target genes decreases cellular amyloid \u03b2 peptide secretion","volume":"278","author":"Sun","year":"2003","journal-title":"J Biol Chem"},{"key":"R67-16-20210205","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M300044200","article-title":"22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid \u03b2 secretion","volume":"278","author":"Koldamova","year":"2003","journal-title":"J Biol Chem"},{"key":"R68-16-20210205","doi-asserted-by":"crossref","first-page":"48508","DOI":"10.1074\/jbc.M209085200","article-title":"Induction of the cholesterol transporter ABCA1 in CNS cells by LXR agonists increases secreted A\u03b2 levels","volume":"277","author":"Fukumoto","year":"2002","journal-title":"J Biol Chem"},{"key":"R69-16-20210205","doi-asserted-by":"crossref","first-page":"43243","DOI":"10.1074\/jbc.M508781200","article-title":"The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's disease","volume":"280","author":"Hirsch-Reinshagen","year":"2005","journal-title":"J Biol Chem"},{"key":"R70-16-20210205","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M504513200","article-title":"Lack of ABCA1 considerably decreased brain apoE level and increases amyloid deposition in APP23 mice","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"},{"key":"R71-16-20210205","doi-asserted-by":"crossref","first-page":"43236","DOI":"10.1074\/jbc.M508780200","article-title":"Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease","volume":"280","author":"Wahrle","year":"2005","journal-title":"J Biol Chem"},{"key":"R72-16-20210205","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1471-4159.2006.03925.x","article-title":"The effects of ABCA1 on cholesterol efflux and A\u03b2 levels in vitro and in vivo","volume":"98","author":"Burns","year":"2006","journal-title":"J Neurochem"},{"key":"R73-16-20210205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1012823120935","article-title":"Complete characterization of the human ABC gene family","volume":"33","author":"Dean","year":"2001","journal-title":"J Bioenerg Biomemb"},{"key":"R74-16-20210205","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0022-2275(20)32205-7","article-title":"Role of ABCG1 and other ABCG family members in lipid metabolism","volume":"42","author":"Schmitz","year":"2001","journal-title":"J Lipid Res"},{"key":"R75-16-20210205","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2005.03369.x","article-title":"Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain","volume":"95","author":"Tachikawa","year":"2005","journal-title":"J Neurochem"},{"key":"R76-16-20210205","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1073\/pnas.97.2.817","article-title":"ABCG1 (ABC8), the human homologue of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport","volume":"97","author":"Klucken","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R77-16-20210205","doi-asserted-by":"crossref","first-page":"30150","DOI":"10.1074\/jbc.M505368200","article-title":"ABCG1 redistributes cell cholesterol to domains removable by HDL but not by lipid-depleted apolipoproteins","volume":"280","author":"Vaughan","year":"2005","journal-title":"J Biol Chem"},{"key":"R78-16-20210205","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R79-16-20210205","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1194\/jlr.M600218-JLR200","article-title":"ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL","volume":"47","author":"Vaughan","year":"2006","journal-title":"J Lipid Res"},{"key":"R80-16-20210205","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-1","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R81-16-20210205","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.M607831200","article-title":"Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein-E discs and suppression of amyloid-\u03b2 peptide generation","volume":"282","author":"Kim","year":"2006","journal-title":"J Biol Chem"},{"key":"R82-16-20210205","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1074\/jbc.M508915200","article-title":"Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia","volume":"281","author":"Karten","year":"2006","journal-title":"J Biol Chem"},{"key":"R84-16-20210205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.med.57.121304.131428","article-title":"Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia","volume":"57","author":"Beaven","year":"2006","journal-title":"Annu Rev Med"},{"key":"R85-16-20210205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","article-title":"LXRS and FXR: the yin and yang of cholesterol and fat metabolism","volume":"68","author":"Kalaany","year":"2006","journal-title":"Annu Rev Physiol"},{"key":"R86-16-20210205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1101\/gad.9.9.1033","article-title":"LXR, a nuclear receptor that defines a distinct retinoid response pathway","volume":"9","author":"Willy","year":"1995","journal-title":"Genes Dev"},{"key":"R87-16-20210205","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.041609298","article-title":"Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor","volume":"98","author":"Claudel","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R88-16-20210205","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors \u03b1 and \u03b2","volume":"277","author":"Repa","year":"2002","journal-title":"J Biol Chem"},{"key":"R89-16-20210205","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand TO901317 decreases amyloid \u03b2 production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J Biol Chem"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOL.0b013e32813aeabf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:37:00Z","timestamp":1786034220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200706000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0b013e32813aeabf","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}